MicroPort Scientific Forecasts Decline in Net Loss for H1 on Higher Revenue

MT Newswires Live07-09

MicroPort Scientific (HKG:0853) forecasts a "significant" decline in its net loss for the six months ended June 30 due to a 17% rise in revenue, according to a Monday filing with the Hong Kong Stock Exchange.

The foreseen growth is attributable to higher revenue in its listed subsidiaries. MicroPort NeuroTech (HKG:2172) registered revenue growth of 34% to 37%, while Shanghai MicroPort Endovascular MedTech (SHA:688016) saw revenue rise 25% to 30%, MicroPort CardioFlow Medtech (HKG:2160) logged a 22% to 28% increase, and Shanghai MicroPort MedBot (HKG:2252) saw revenue surge 103% to 108%, the filing said.

Microport plans to release first-half results by the end of August.

Shares closed 3% lower in Hong Kong during Tuesday's afternoon trading.

Price (HKD): $5.16, Change: $-0.18, Percent Change: -3.37%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2450012132?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-07-09 18:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2450012132","market":"nz","top_or_hot":-1,"title":"MicroPort Scientific Forecasts Decline in Net Loss for H1 on Higher Revenue","media":"MT Newswires Live","content":"<html><body><p> MicroPort Scientific (HKG:0853) forecasts a \"significant\" decline in its net loss for the six months ended June 30 due to a 17% rise in revenue, according to a Monday filing with the Hong Kong Stock Exchange.</p><p>The foreseen growth is attributable to higher revenue in its listed subsidiaries. MicroPort NeuroTech (HKG:2172) registered revenue growth of 34% to 37%, while Shanghai MicroPort Endovascular MedTech (SHA:688016) saw revenue rise 25% to 30%, MicroPort CardioFlow Medtech (HKG:2160) logged a 22% to 28% increase, and Shanghai MicroPort MedBot (HKG:2252) saw revenue surge 103% to 108%, the filing said.</p><p>Microport plans to release first-half results by the end of August.</p><p>Shares closed 3% lower in Hong Kong during Tuesday's afternoon trading.</p><p>Price (HKD): $5.16, Change: $-0.18, Percent Change: -3.37%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MicroPort Scientific Forecasts Decline in Net Loss for H1 on Higher Revenue</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicroPort Scientific Forecasts Decline in Net Loss for H1 on Higher Revenue\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-09 18:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MicroPort Scientific (HKG:0853) forecasts a \"significant\" decline in its net loss for the six months ended June 30 due to a 17% rise in revenue, according to a Monday filing with the Hong Kong Stock ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02172","symbol_name":"微创脑科学","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2450012132","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2450012132","pubTimestamp":1720521398,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"MicroPort Scientific  forecasts a \"significant\" decline in its net loss for the six months ended June 30 due to a 17% rise in revenue, according to a Monday filing with the Hong Kong Stock Exchange.The foreseen growth is attributable to higher revenue in its listed subsidiaries. MicroPort NeuroTech  registered revenue growth of 34% to 37%, while Shanghai MicroPort Endovascular MedTech  saw revenue rise 25% to 30%, MicroPort CardioFlow Medtech  logged a 22% to 28% increase, and Shanghai MicroPort MedBot  saw revenue surge 103% to 108%, the filing said.Microport plans to release first-half results by the end of August.Shares closed 3% lower in Hong Kong during Tuesday's afternoon trading.Price : $5.16, Change: $-0.18, Percent Change: -3.37%","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"688016":"心脉医疗","02172":"微创脑科学","02252":"微创机器人-B","02160":"心通医疗-B","00853":"微创医疗"},"translate_title":"微创医疗预计上半年净亏损将因收入增加而下降","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688016":0.9,"00853":0.9,"02160":0.9,"02172":0.9,"02252":0.9},"content_text":"MicroPort Scientific (HKG:0853) forecasts a \"significant\" decline in its net loss for the six months ended June 30 due to a 17% rise in revenue, according to a Monday filing with the Hong Kong Stock Exchange.The foreseen growth is attributable to higher revenue in its listed subsidiaries. MicroPort NeuroTech (HKG:2172) registered revenue growth of 34% to 37%, while Shanghai MicroPort Endovascular MedTech (SHA:688016) saw revenue rise 25% to 30%, MicroPort CardioFlow Medtech (HKG:2160) logged a 22% to 28% increase, and Shanghai MicroPort MedBot (HKG:2252) saw revenue surge 103% to 108%, the filing said.Microport plans to release first-half results by the end of August.Shares closed 3% lower in Hong Kong during Tuesday's afternoon trading.Price (HKD): $5.16, Change: $-0.18, Percent Change: -3.37%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2450012132"}